Biomerica (BMRA) Equity Average (2016 - 2025)
Historic Equity Average for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $4.8 million.
- Biomerica's Equity Average fell 831.74% to $4.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $4.8 million, marking a year-over-year decrease of 831.74%. This contributed to the annual value of $5.3 million for FY2025, which is 4159.98% down from last year.
- Per Biomerica's latest filing, its Equity Average stood at $4.8 million for Q4 2025, which was down 831.74% from $4.6 million recorded in Q3 2025.
- In the past 5 years, Biomerica's Equity Average ranged from a high of $11.2 million in Q3 2023 and a low of $4.6 million during Q3 2025
- Moreover, its 5-year median value for Equity Average was $8.5 million (2022), whereas its average is $7.8 million.
- In the last 5 years, Biomerica's Equity Average surged by 16993.66% in 2021 and then crashed by 4809.19% in 2024.
- Over the past 5 years, Biomerica's Equity Average (Quarter) stood at $8.9 million in 2021, then decreased by 12.09% to $7.8 million in 2022, then rose by 29.47% to $10.1 million in 2023, then plummeted by 48.09% to $5.2 million in 2024, then fell by 8.32% to $4.8 million in 2025.
- Its Equity Average was $4.8 million in Q4 2025, compared to $4.6 million in Q3 2025 and $4.8 million in Q2 2025.